Erlotinib Hydrochloride

Erlotinib Hydrochloride

• Background: Erlotinib Hydrochloride inhibits the human epidermal growth factor receptor (HER-1/EGFR) tyrosine kinase.
• Description: EGFR Kinase inhibitor
• Product Name Alternative: N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride
• CAS Number: 183319-69-9
• UNSPSC: 41116105
• Source: Synthetic
• Purity: ≥99%
• Weight: 0.01
• Format: Solid powder
• Solubility: Soluble in DMSO at 18 mg/ml with warming; very poorly soluble in ethanol; very poorly soluble in water; maximum solubility in plain water is estimated to be about 5-20 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility
• Molecular Formula: C22H24ClN3O4
• Molecular Weight: 429.9
• Precautions: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
• References & Citations: 1. Ali S., et al. (2008) Mol. Cancer Ther. 7(6): 1708–1719.